Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 28, 2024 07:00 ET | Source: Rentschler Biopharma SE

Rentschler Biopharma Appoints Patrick Meyer as Global Head BD Sales and Alliance Management

LAUPHEIM, Germany and MILFORD, Mass. and STEVENAGE, United Kingdom, May 28, 2024 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization...
May 02, 2024 08:00 ET | Source: Rentschler Biopharma SE

Rentschler Biopharma Appoints Patrick Cushing as VP Operations for U.S. Subsidiary

LAUPHEIM, Germany and MILFORD, Mass. and STEVENAGE, United Kingdom, May 02, 2024 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization...
March 13, 2024 09:30 ET | Source: Rentschler Biopharma SE

Rentschler Biopharma Takes Home the Gold in 20th Annual Team Massachusetts Economic Impact Awards

Company honored with highest award for Central Massachusetts regionNew state-of-the-art Rentschler Biopharma Manufacturing Center (RBMC) facility slated to open for business later this year ...
March 06, 2024 04:00 ET | Source: Rentschler Biopharma SE

Rentschler Biopharma contributes to nearly 25% of FDA approved biopharmaceuticals in 2023

Exceptional capabilities in guiding therapies from early-stage development through to market based on over 50 years of biotech experience LAUPHEIM, Germany and MILFORD, Mass. and STEVENAGE, United...
February 06, 2024 08:00 ET | Source: Rentschler Biopharma SE

Senta Brandt and Gerrick Rodrigues appointed to Global Leadership Positions at Rentschler Biopharma

Senta Brandt promoted to global position of Head of TransformationGerrick Rodrigues promoted to Global Head of IT LAUPHEIM, Germany and MILFORD, Mass. and STEVENAGE, United Kingdom, Feb. 06, 2024 ...
December 20, 2023 07:00 ET | Source: Rentschler Biopharma SE

Rentschler Biopharma Announces Major Client Project for New U.S. Facility at Milford, MA Site

State-of-the-art Rentschler Biopharma Manufacturing Center (RBMC) facility slated to open for business next year LAUPHEIM, Germany and MILFORD, Mass., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Rentschler...
December 07, 2023 04:00 ET | Source: Rentschler Biopharma SE

Rentschler Biopharma SE appoints Gunnar Voss von Dahlen as Chief Financial Officer and completes Executive Board

LAUPHEIM, Germany and MILFORD, Mass. and STEVENAGE, United Kingdom, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading contract development and manufacturing organization (CDMO)...
September 19, 2023 05:00 ET | Source: Rentschler Biopharma SE

Rentschler Biopharma appoints Benedikt von Braunmuehl as Chief Executive Officer

Benedikt von Braunmuehl, a transformational leader with a 30-year track record in the global healthcare industry, is named CEO Rentschler Biopharma SECompany also announces appointment of Tom Roberts,...
September 13, 2023 03:00 ET | Source: Rentschler Biopharma SE

Rentschler Biopharma’s ATMP facility in Stevenage, UK, receives MHRA approval

UK site now set for clinical production of adeno-associated virus (AAV) vectors for gene therapyHighly experienced team ready to support ATMP innovators at all stagesOffering comprehensive range of...
June 01, 2023 05:09 ET | Source: Rentschler Biopharma SE

Rentschler Biopharma joins forces with Ikarovec to accelerate novel gene therapies for treatment of ophthalmic disease

Rentschler Biopharma to conduct adeno-associated virus (AAV) process development work for manufacturing scale-up at their ATMP site in Stevenage, UKIkarovec is developing novel gene therapies to treat...